Related Experiment Video
Updated: Jun 16, 2026
09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Inadequacies of absolute threshold levels for diagnosing prediabetes
1NYU School of Medicine, Division of Endocrinology, NYU Diabetes and Endocrine Associates, 345 East 37th Street, New York, NY 10016, USA. michael.bergman@med.nyu.edu
Diabetes/Metabolism Research and Reviews
|January 27, 2010
Summary
Prediabetes, including Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT), signals increased risks for diabetes and heart disease. Earlier detection and intervention are crucial, as even lower glucose levels pose risks, especially in high-risk individuals.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Public Health
Background:
- Prediabetes, encompassing Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT), is a critical intermediate stage preceding type 2 diabetes mellitus.
- This metabolic stage is linked to elevated risks of developing diabetes and cardiovascular disease.
- Current diagnostic criteria may miss individuals at risk, as glucose levels below the prediabetes threshold can also confer significant health risks, particularly in high-risk populations.
Purpose of the Study:
- To highlight the public health implications of unrecognized prediabetes.
- To emphasize the association between glucose levels below current prediabetes definitions and increased health risks.
- To advocate for earlier intervention strategies for individuals at risk of type 2 diabetes.
Main Methods:
- Review of existing evidence on glucose metabolism and associated risks.
- Analysis of diagnostic criteria for prediabetes (IFG and IGT).
- Assessment of cardiovascular and diabetes risks in relation to varying glucose levels.
Main Results:
- Prediabetes (IFG/IGT) is a significant risk factor for type 2 diabetes and cardiovascular disease.
- Glucose levels lower than current prediabetes definitions are associated with similar risks, especially in high-risk individuals.
- A substantial number of individuals with prediabetes remain undiagnosed, posing a public health challenge.
Conclusions:
- Earlier identification of individuals at risk for type 2 diabetes is necessary.
- Intervention strategies should be considered for glucose levels below the established prediabetes range, particularly in high-risk groups.
- Addressing unrecognized prediabetes is essential for mitigating future diabetes and cardiovascular disease burdens.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...